6 Biotechnology Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Genprex, Inc. GNPX shares rose 48.7% to $1.71 during Wednesday's pre-market session.

• Akcea Therapeutics, Inc. AKCA shares moved upwards by 16.6% to $20.21. The most recent rating by BMO Capital, on November 06, is at Outperform, with a price target of $36.00.

• Advaxis, Inc. ADXS stock surged 5.8% to $1.10.

• Moderna, Inc. MRNA stock increased by 5.3% to $22.05. The most recent rating by Bank of America, on December 03, is at Buy, with a price target of $29.00.

• BioLine Rx, Inc. BLRX stock surged 4.0% to $2.59.

Losers

• Novavax, Inc. NVAX shares plummeted 13.4% to $8.50 during Wednesday's pre-market session.